Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,408,400 | 2,390,500 | 4,684,800 | 4,088,600 | 4,347,700 |
| Depreciation Amortization | 1,427,700 | 1,379,000 | 1,445,600 | 1,462,200 | 1,373,600 |
| Income taxes - deferred | -748,400 | 36,800 | 265,900 | 126,000 | -268,500 |
| Accounts receivable | -304,500 | 117,400 | -152,700 | 361,800 | -188,800 |
| Accounts payable and accrued liabilities | 207,900 | -809,000 | -70,300 | -336,100 | 591,400 |
| Other Working Capital | -1,139,200 | -325,500 | -393,000 | -51,200 | 1,248,400 |
| Other Operating Activity | 1,112,700 | 1,669,200 | -45,300 | -346,500 | 130,700 |
| Operating Cash Flow | $2,964,600 | $4,458,400 | $5,735,000 | $5,304,800 | $7,234,500 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,319,600 | 2,416,300 | 1,789,100 | 375,100 | -250,900 |
| PPE Investments | -973,600 | -1,147,300 | -832,700 | -883,400 | -646,700 |
| Net Acquisitions | -5,283,100 | -551,400 | -43,700 | -199,300 | -307,800 |
| Purchase Of Investment | -3,226,500 | -9,802,700 | -14,041,900 | -7,618,600 | -4,624,400 |
| Sale Of Investment | 3,068,400 | 11,009,400 | 11,235,000 | 4,355,700 | 2,138,500 |
| Purchase Sale Intangibles | 410,000 | -308,300 | -24,100 | -138,800 | -632,900 |
| Other Investing Activity | 5,122,000 | -5,833,400 | -178,600 | 1,137,700 | -1,133,100 |
| Investing Cash Flow | $26,800 | $-3,909,100 | $-2,072,800 | $-2,832,800 | $-4,824,400 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -2,680,600 | 2,680,600 | 0 | 0 | -134,100 |
| Debt Issued | 4,454,700 | 992,900 | 0 | 0 | N/A |
| Debt Repayment | -1,955,700 | -1,034,800 | -10,500 | -1,511,100 | -61,700 |
| Common Stock Repurchased | -749,500 | -800,000 | -1,698,100 | -721,100 | 0 |
| Dividend Paid | -2,127,300 | -2,101,200 | -2,120,700 | -2,187,400 | -2,180,100 |
| Other Financing Activity | -52,600 | 96,100 | 0 | 0 | 6,000 |
| Financing Cash Flow | $-3,111,000 | $-166,400 | $-3,829,300 | $-4,419,600 | $-2,369,900 |
| Exchange Rate Effect | -85,600 | -341,500 | -21,500 | 43,900 | -110,900 |
| Beginning Cash Position | 3,871,600 | 3,830,200 | 4,018,800 | 5,922,500 | 5,993,200 |
| End Cash Position | 3,666,400 | 3,871,600 | 3,830,200 | 4,018,800 | 5,922,500 |
| Net Cash Flow | $-205,200 | $41,400 | $-188,600 | $-1,903,700 | $-70,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,964,600 | 4,458,400 | 5,735,000 | 5,304,800 | 7,234,500 |
| Capital Expenditure | -1,066,200 | -1,162,600 | -1,012,100 | -905,400 | -672,000 |
| Free Cash Flow | 1,898,400 | 3,295,800 | 4,722,900 | 4,399,400 | 6,562,500 |